Breaking News, Promotions & Moves

CrownBio Expands Life Science Division

Will expand product portfolio; names Debby Saunders executive director

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, has unveiled plans to increase focus on the life science division of the organization. CrownBio’s life science division currently provides more than one hundred products across a portfolio of antibodies for in vivo and in vitro studies, recombinant proteins, recombinant cell lines, tumor samples for oncology research and drug ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters